APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 94 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $43,000 | -21.8% | 10,875 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $55,000 | -26.7% | 10,875 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $75,000 | -97.2% | 10,875 | -96.2% | 0.00% | -97.3% |
| Q4 2016 | $2,651,000 | -6.6% | 283,551 | -2.2% | 0.11% | -10.3% |
| Q3 2016 | $2,837,000 | -31.0% | 290,046 | -0.3% | 0.13% | -36.4% |
| Q2 2016 | $4,109,000 | -2.6% | 290,784 | -3.7% | 0.20% | -3.4% |
| Q1 2016 | $4,220,000 | +12.1% | 301,864 | +63.5% | 0.20% | +15.2% |
| Q4 2015 | $3,766,000 | – | 184,610 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |